AcquiredStartups
Acquirer · Corporate

AstraZeneca

1Exits trackedUndisclosedDisclosed value—Median price0Acquihires
Photo: Ajay Kumar Chaurasiya / Wikimedia Commons, CC BY-SA 4.0
Healthtech & bio · St. Louis

AstraZeneca acquires St. Louis vaccine startup Omniose after three-year research partnership

The drugmaker already had exclusive rights to Omniose's single-cell bioconjugation platform through a 2024 collaboration. Now it owns the company outright and has folded it into its infectious disease unit.

PriceUndisclosedRaisedn/aLast stageStage n/aBuyer typeCorporate
Latest in AstraZenecaMore stories here soon.